Myocarditis is a cardiac disease associated with inflammation and injury of the myocardium. It results from various etiologies, both noninfectious and infectious, but coxsackievirus B3 (CVB3) is still considered the dominant etiological agent. Myocarditis may be caused by direct cytopathic effects of virus, a pathologic immune response to persistent virus, or autoimmunity triggered by the viral infection. The virus enters the myocyte through internalization of the coxsackie-adenoviral receptor (CAR) and its coreceptor, decay-accelerating factor (DAF). Viral proteases cleave various proteins in the host cell. One example is viral protease 2A, which cleaves eukaryote initiation factor 4G (eIF4G) and the dystrophin protein, resulting in a complete shutdown of cap-dependent RNA translation and cytoskeletal destruction in infected cardiomyocytes, respectively. CVB3 also cleaves the member of the Bcl-2 family Bid, leading to apoptosis. CVB3 infection also induces the cleavage of cyclin D protein through a proteasome-dependent pathway, leading to the host cell-growth arrest. Viral infection and necrosis of myocytes may lead to the release of intracellular antigens, resulting in activation of self-reactive T cells. CVB infection is a significant cause of dilated cardiomyopathy (DCM) as well as myocarditis. Epidemiologically, myocarditis underlies a significant portion of patients with DCM.

Human Diseases; Cardiovascular disease
BRITE hierarchy

Miniopterus natalensis [GN:mna]

PMID:18039131

Esfandiarei M, McManus BM

Molecular biology and pathogenesis of viral myocarditis.

Annu Rev Pathol 3:127-55 (2008)
DOI:10.1146/annurev.pathmechdis.3.121806.151534

PMID:12920582

Badorff C, Knowlton KU

Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.

Med Microbiol Immunol 193:121-6 (2004)
DOI:10.1007/s00430-003-0189-7

PMID:17200452

Maekawa Y, Ouzounian M, Opavsky MA, Liu PP

Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.

Circulation 115:5-8 (2007)
DOI:10.1161/CIRCULATIONAHA.106.670554

PMID:12439638

Pankuweit S, Portig I, Maisch B

Pathophysiology of cardiac inflammation: molecular mechanisms.

Herz 27:669-76 (2002)
DOI:10.1007/s00059-002-2421-4

PMID:16845885

Gao G, Luo H

The ubiquitin-proteasome pathway in viral infections.

Can J Physiol Pharmacol 84:5-14 (2006)
DOI:10.1139/y05-144

PMID:16413486

Coyne CB, Bergelson JM

Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.

Cell 124:119-31 (2006)
DOI:10.1016/j.cell.2005.10.035

PMID:10904843

Badorff C, Lee GH, Knowlton KU

Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.

Herz 25:227-32 (2000)
DOI:10.1007/s000590050011

PMID:18357777

Knowlton KU

CVB infection and mechanisms of viral cardiomyopathy.

Curr Top Microbiol Immunol 323:315-35 (2008)
DOI:10.1007/978-3-540-75546-3_15

PMID:18545064

Castellano G, Affuso F, Di Conza P, Fazio S

Myocarditis and dilated cardiomyopathy: possible connections and treatments.

J Cardiovasc Med (Hagerstown) 9:666-71 (2008)
DOI:10.2459/JCM.0b013e3282f3e9c2

PMID:19357408

Cooper LT Jr

Myocarditis.

N Engl J Med 360:1526-38 (2009)
DOI:10.1056/NEJMra0800028

PMID:10051305

Kawai C

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.

Circulation 99:1091-100 (1999)
DOI:10.1161/01.CIR.99.8.1091

PMID:11524405

Liu PP, Mason JW

Advances in the understanding of myocarditis.

Circulation 104:1076-82 (2001)
DOI:10.1161/hc3401.095198

PMID:14522402

Mason JW

Myocarditis and dilated cardiomyopathy: an inflammatory link.

Cardiovasc Res 60:5-10 (2003)
DOI:10.1016/S0008-6363(03)00437-1

PMID:16817756

Tam PE

Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.

Viral Immunol 19:133-46 (2006)
DOI:10.1089/vim.2006.19.133